Aquestive Therapeutics
AQST
AQST
45 hedge funds and large institutions have $10.8M invested in Aquestive Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
73% less capital invested
Capital invested by funds: $40.7M → $10.8M (-$29.9M)
Holders
45
Holding in Top 10
1
Calls
$33K
Puts
$9K
Top Buyers
| 1 | +$763K | |
| 2 | +$543K | |
| 3 | +$80K | |
| 4 |
VF
Virtu Financial
New York
|
+$61.2K |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$39K |
Top Sellers
| 1 | -$1.08M | |
| 2 | -$340K | |
| 3 | -$265K | |
| 4 |
Man Group
London,
United Kingdom
|
-$235K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$166K |